SCHEMBL19989710

SCHEMBL19989710

COC(=O)C(C)(CN1CC=C(c2ccc(-c3ccccc3)cc2)CC1)S(C)(=O)=O

nearest known ligand 0.49

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 8/20 0.49
MMP2 P08253 1/20 0.47
MMP3 P08254 1/20 0.47
MAPT P10636 5/20 0.45
DRD3 P35462 1/20 0.45
SIGMAR1 Q99720 3/20 0.45
GAA P10253 1/20 0.43
LMNA P02545 3/20 0.43
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
PPARG P37231 1/20 0.41
PPARA Q07869 1/20 0.41
TDP1 Q9NUW8 2/20 0.41
SLC6A2 P23975 1/20 0.41
MMP12 P39900 1/20 0.41
MMP13 P45452 1/20 0.41
ALDH1A1 P00352 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19989695 0.89 KDM4E (0.50) KDM4EMMP2MMP3MAPTSIGMAR1
SCHEMBL19989648 0.87 SLC6A2 (0.54) KDM4EMMP2MMP3MAPTSIGMAR1
SCHEMBL20025606 0.83 KDM4E (0.52) KDM4EMMP2MMP3MAPTDRD3
SCHEMBL20025273 0.82 KDM4E (0.51) KDM4EMMP2MMP3MAPTDRD3
SCHEMBL19989698 0.79 SIGMAR1 (0.45) KDM4EDRD3SIGMAR1PPARGPPARA
SCHEMBL19989646 0.79 PPARG (0.41) KDM4EMAPTDRD3SIGMAR1PPARG
SCHEMBL19989620 0.79 SLC6A2 (0.57) KDM4EMMP2MMP3SLC6A2MMP12
SCHEMBL19989634 0.79 KDM4E (0.41) KDM4EMMP2MMP3MAPTSIGMAR1
SCHEMBL19989638 0.79 PPARG (0.39) KDM4EMMP2MMP3DRD3SIGMAR1
SCHEMBL19989683 0.75 KDM4E (0.41) KDM4EMAPTGAAKMT2APPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3519387-B1 TETRAHYDROPYRIDINE DERIVATIVES AND THEIR USE AS ANTIBACTERIAL AGENTS DONG A ST CO LTD (KR) 2021-08-11 EP disclosed
EP-3519387-B1 TETRAHYDROPYRIDINE DERIVATIVES AND THEIR USE AS ANTIBACTERIAL AGENTS DONG A ST CO LTD (KR) 2021-08-11 EP disclosed
EP-3519387-A1 TETRAHYDROPYRIDINE DERIVATIVES AND THEIR USE AS ANTIBACTERIAL AGENTS Dong-A ST Co., Ltd. (KR) 2019-08-07 EP disclosed
US-10160724-B2 Tetrahydropyridine derivatives and their use as antibacterial agents DONG-A ST CO., LTD. (KR) 2018-12-25 US disclosed
WO-2018062924-A1 TETRAHYDROPYRIDINE DERIVATIVES AND THEIR USE AS ANTIBACTERIAL AGENTS DONG-A ST CO., LTD. (KR) 2018-04-05 WO disclosed
WO-2018062924-A1 TETRAHYDROPYRIDINE DERIVATIVES AND THEIR USE AS ANTIBACTERIAL AGENTS DONG-A ST CO., LTD. (KR) 2018-04-05 WO disclosed
US-20180086709-A1 TETRAHYDROPYRIDINE DERIVATIVES AND THEIR USE AS ANTIBACTERIAL AGENTS DONG-A ST CO., LTD. (KR) 2018-03-29 US disclosed
US-20180086709-A1 TETRAHYDROPYRIDINE DERIVATIVES AND THEIR USE AS ANTIBACTERIAL AGENTS DONG-A ST CO., LTD. (KR) 2018-03-29 US disclosed
US-20180086709-A1 TETRAHYDROPYRIDINE DERIVATIVES AND THEIR USE AS ANTIBACTERIAL AGENTS DONG-A ST CO., LTD. (KR) 2018-03-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180086709-A1 TETRAHYDROPYRIDINE DERIVATIVES AND THEIR USE AS ANTIBACTERIAL AGENTS GALE, UGDH, PGLS KDM4E 972/4885MMP2 314/4885MMP3 358/4885
US-10160724-B2 Tetrahydropyridine derivatives and their use as antibacterial agents GALE, UGDH, PGLS KDM4E 972/4885MMP2 314/4885MMP3 358/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.